항생제에 내성이 생긴다면 우리는 어떻게 해야할까요?

The first report from a two-year project, commissioned by the Prime Minister of the United Kingdom and headed by the former chief economist of Goldman Sachs, delivers a jaw-dropping estimate of the costs of antibiotic resistance: by the year 2050, up to 10 millions deaths per year, and lost productivity equal to $100 trillion.

For decades the European Union led the world in taking legislative and regulatory action to reduce antibiotic use and combat resistance. Now the Obama administration has taken action too, with a multi-part plan that could turn out to be a significant legacy.

This book by the Chief Medical Officer of the United Kingdom sketches an apocalyptic future in which people who contract everyday infections are locked into isolation until they recover or die.

In this article (a finalist for a James Beard Award), I explain how losing antibiotics would undermine not only medicine, but the food supply, our daily lives and much of what holds modern society together.

My 2010 book started my exploration of antibiotic resistance. It presents the story of the rise of resistant organisms through the biography of one bug, MRSA (drug-resistant staph), which has created overlapping epidemics in hospitals, families and farms.